Literature DB >> 23999830

No impact of early real-time PCR screening for respiratory viruses on length of stay and use of antibiotics in elderly patients hospitalized with symptoms of a respiratory tract infection in a single center in Norway.

S S Hernes1, E Hagen, H Quarsten, B Bjorvatn, P S Bakke.   

Abstract

We tested the hypothesis that the results of real-time polymerase chain reaction (PCR) analyses for respiratory viruses would reduce antibiotic treatment and length of stay in elderly patients hospitalized with respiratory infections. Within 24 h of hospital admission, a total of 922 patients aged ≥60 years were interviewed for symptoms of ongoing respiratory tract infection. Symptomatic patients were swabbed for oropharyngeal/nasopharyngeal presence of viral pathogens immediately by members of the study group. During a 2-month period, non-symptomatic volunteers among interviewed patients were swabbed as well (controls). Oropharyngeal/nasopharyngeal swabs were analyzed with real-time PCR for nine common respiratory viruses. A total of 147 out of 173 symptomatic patients and 56 non-symptomatic patients (controls) agreed to participate in the study. The patients were allocated to three cohorts: (1) symptomatic and PCR-positive (S/PCR+), (2) symptomatic and PCR-negative (S/PCR-), or (3) non-symptomatic and PCR-negative (control). There were no non-symptomatic patients with a positive PCR result. A non-significant difference in the frequency of empiric antibiotic administration was found when comparing the S/PCR+ to the S/PCR- cohort; 16/19 (84 %) vs. 99/128 (77 %) (χ(2) = 0.49). Antibiotic treatment was withdrawn in only two patients in the S/PCR+ cohort after receiving a positive viral diagnosis. The length of stay did not significantly differ between the S/PCR+ and the S/PCR- groups. We conclude that, at least in our general hospital setting, access to early viral diagnosis by real-time PCR had little impact on the antimicrobial treatment or length of hospitalization of elderly patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999830      PMCID: PMC7088319          DOI: 10.1007/s10096-013-1963-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


Introduction

Respiratory viral infections (RVIs) are important causes of morbidity and death in the elderly population [1-3]. Influenza viruses, respiratory syncytial virus (RSV), and human metapneumovirus (hMPV) are the major viral pathogens in the geriatric age group, and outbreaks caused by these viruses have been described in long-term care facilities [4, 5]. Following infection with influenza viruses, RSV, or hMPV, the risk of hospitalization increases with underlying heart and lung disease [6-8]. So far, vaccines and antiviral drugs are available for influenza viruses, but not for RSV and hMPV. Both in the community and in hospitals, the burden of diseases caused by RVIs among the elderly is difficult to establish, as symptoms are often uncharacteristic [9]. Apart from the sensitivity and specificity of the involved laboratory methods, successful etiological diagnosis of RVIs depends on virus-specific factors such as the extent of shedding, as well as on the patient’s age and medical condition [10-12]. Real-time polymerase chain reaction (PCR) assays can provide a rapid etiological diagnosis more efficiently than conventional microbiological methods [13]. Therefore, real-time PCR may contribute to reducing the inappropriate use of antibiotics and to shortening the length of hospitalization. The high diagnostic sensitivity of real-time PCR may be of special value in viral respiratory infections of the elderly, who, at least in the case of RSV, are characterized by low mucosal shedding of the virus [9, 14]. In children, rapid tests for respiratory viruses have reduced the duration of hospitalization, antibiotic prescription, and the cost of hospitalization [15, 16]. Similar findings have been observed in young and middle-aged adults [17]. However, limited data are available on the effect of improved microbiological diagnostics in the elderly population [6]. We hypothesized that early results of real-time PCR analyses for respiratory viruses would reduce antibiotic treatment and length of stay in elderly patients hospitalized with respiratory infections. The objective of this study was to test this hypothesis in a general medical ward.

Materials and methods

Ethical committee

The study design was approved by the Norwegian Regional Committee of Research Ethics.

Study design and eligibility criteria

The study took place from February 13th 2008 until February 3rd 2009 at the Department of Internal Medicine, Sorlandet Hospital Arendal, Norway. Sorlandet Hospital Arendal is the only hospital in Aust-Agder County, serving approximately 111,000 inhabitants. A total of 66 % of the population are residing in densely populated areas. At the time of the study, regional antibiotic stewardship suggested the use of intravenous penicillin G in patients with a suspected respiratory bacterial infection. A four-hour rule existed on antibiotic initiation after hospital admission, leaving the probability of antibiotic administration in patients with symptoms consistent with a respiratory infection being high. Twice a week, all patients born in 1948 or earlier and admitted to the department during the previous day were interviewed by one out of two specially trained team members of the study group (one doctor or one nurse) for any symptoms of ongoing respiratory tract infection and for details of possible ongoing antimicrobial therapy, regardless of findings and diagnosis upon admission. Out of a total of 922 interviewed patients, 173 (19 %) were eligible according to the pre-set inclusion criteria (Table 1) and 147/173 patients agreed to be tested according to the study protocol. Of the 26 patients who declined to participate, 14 were males and 12 females; their mean age was 74.8 [standard deviation (SD) 7.9] years. As a control group for possible mucosal carriers of respiratory viruses among non-symptomatic individuals, 23 patients without symptoms of a respiratory tract infection were swabbed once during the first 4 weeks and 33 similar patients once during the last 4 weeks of the study (Table 1).
Table 1

Inclusion criteria

Inclusion criteria
Symptomatic patients

Patients born in 1948 or earlier

AND at least one of the following current symptoms with debut less than 3 weeks prior:

 • Nasal congestion or runny nose

 • Throat pain

 • Fever (>38 °C)

 • Malaise

 • Muscle pain

 • Self-diagnosis of “the common cold”

 • Diarrhea or eye infection combined with laboratory values supporting an infection

Non-symptomatic patientsPatients born in 1948 or earlier
Inclusion criteria Patients born in 1948 or earlier AND at least one of the following current symptoms with debut less than 3 weeks prior: • Nasal congestion or runny nose • Throat pain Fever (>38 °C) • Malaise • Muscle pain • Self-diagnosis of “the common cold” Diarrhea or eye infection combined with laboratory values supporting an infection Two nasopharyngeal swabs, two oropharyngeal swabs, and two serum samples were collected per patient immediately after the interviews, as previously described [18]. The swabbed material was analyzed by real-time PCR for influenza virus A and B, parainfluenza-virus 1–4, RSV A and B, hMPV, and adenovirus. Data for analysis in this paper were obtained during a study examining the sampling efficacy of rayon and nylon flocked swabs for the diagnosis of RVIs in the elderly [18]. PCR results were communicated to the attending physician within 24–48 h after sampling. A change in antibiotic treatment within 48 h after communication of the PCR results were viewed as a direct response to the PCR results. We defined three cohorts of patients: symptomatic subjects with a positive real-time PCR (S/PCR+); symptomatic subjects with negative PCR (S/PCR−); non-symptomatic control subjects with negative PCR (control). Additionally, two subgroups of patients were identified for further analysis: (1) patients admitted by general practitioners to the hospital with a tentative diagnosis of pneumonia and (2) patients with chest X-ray at admittance consistent with pneumonia.

Additional examinations

To compare their respective comorbidities at the time of admission, the patients in these three groups were scored with the Modified Cumulative Illness Rating Scale for Geriatrics (CIRS-G) by Miller et al. [19], with subsequent modifications [20, 21] and the Charlson comorbidity index (CCI), as described by Extermann [22]. Also, C-reactive protein (CRP) analysis, leukocyte counts, and assessments of chest X-rays were routinely performed on all patients at the time of admission. Leukocyte counts above 10.5 G/L and CRP values above 100 mg/L were considered signs of a bacterial infection and, when combined with an X-ray finding consistent with pneumonia, an indication of bacterial pneumonia [23]. The CRP value upon admission as well as the maximum CRP level during hospitalization were noted, whereas leukocytes were registered at the time of admission only.

Statistics

Continuous data analysis was performed by non-parametric methods using the Kruskal–Wallis test for skewed data, as well as Student’s t-test for normally distributed data. Categorical data analysis was performed by the use of Pearson’s Chi-squared test. Length of stay analysis was performed by the use of Cox regression. One-way analysis of variance (ANOVA) with Bonferroni corrections were performed when comparing groups. Two-tailed p-values less than 0.05 were considered significant. All statistical analyses were performed using PASW 18 (SPSS Inc., Quarry Bay, Hong Kong).

Results

The results of the PCR analyses are published elsewhere [18]. Briefly, a positive real-time PCR test was obtained with at least one swab in 19 out of 147 patients: seven tested positive for influenza A virus, three for RSV, three for hMPV, two for adenovirus, two for parainfluenza virus type 3, one for influenza B virus, and one for parainfluenza virus type 4 [18]. None of the controls had a positive PCR. The characteristics of the three groups are described in Table 2. The mean age and proportion living in a nursing home differed between the groups, being highest in the S/PCR+ group and lowest in the control group. Diagnosis at admittance is described in Online resource 1.
Table 2

Characteristics of the study population

S/PCR+S/PCR−Control p-Value/χ2
Number of patients1912856
Male gender, %42.160.266.10.183a
Age, mean (SD), years79 (8)76 (9)71 (9)0.002b
Smoking, %27.828.128.60.997a
Living in a nursing home, %21.111.31.80.027a
Leukocyte count at admission, mean (SD), G/L10.3 (6.0)12.4 (5.8)8.22 (2.6)0.000b
Maximum CRP, median (25th/75th percentile)60.0 (39/140)119.0 (56.5/227)11.5 (2/44)<0.001b
Pneumonia at admission, %37312<0.001a
In-hospital antibiotic treatment, %847714<0.001a
Total CIRS-G score, median, (25th/75th percentile)11 (8/14)12 (9/16)11 (8/15)0.739a
CIRS-G respiratory, median (25th/75th percentile)2 (0/4)3 (0/4)0 (0/2)<0.001a
CIRS-G cardiac, median, (25th/75th percentile)2 (1/2)2 (0/3)3 (0/3)0.010a
CCI, median (25th/75th percentile)1 (0/2)2 (1/2)1 (1/2)0.525a
Length of hospitalization, median (25th/75th percentile)3.9 (2.7/7.2)3.9 (2.3/6.8)2.2 (1.2/3.8)0.001c

Characteristics of the study population divided into three groups: symptomatic and PCR-positive (S/PCR+), symptomatic and PCR-negative (S/PCR−), and non-symptomatic control (control)

CIRS-G Modified Cumulative Illness Rating Scale for Geriatrics; CCI Charlson comorbidity index

aPearson’s Chi-squared test

bOne-way analysis of variance (ANOVA)

cCox regression

Characteristics of the study population Characteristics of the study population divided into three groups: symptomatic and PCR-positive (S/PCR+), symptomatic and PCR-negative (S/PCR−), and non-symptomatic control (control) CIRS-G Modified Cumulative Illness Rating Scale for Geriatrics; CCI Charlson comorbidity index aPearson’s Chi-squared test bOne-way analysis of variance (ANOVA) cCox regression The frequency of diagnosed pneumonia by chest X-ray and the frequency of antibiotic treatment during hospitalization did not differ between the S/PCR+ and S/PCR− symptomatic cohorts (Table 2), while pneumonia and antibiotic treatment was significantly lower in the control group. A total of 19/37 (51 %) of the patients receiving a tentative diagnosis of pneumonia at admission by the general practitioners had their pneumonia confirmed by chest X-ray. With no exception, the patients with a tentative diagnosis of pneumonia at admission and/or patients with a chest X-ray consistent with pneumonia were administered antibiotics immediately after hospitalization. When the PCR results became available, only two of the 16 patients (12.5 %) in the S/PCR+ cohort had their antimicrobial treatment discontinued. In both cases, the PCR results were stated as the main reason for antibiotic discontinuation in the patients’ charts. Both patients were admitted by general practitioners with a diagnosis of pneumonia, and one of these had chest X-rays consistent with pneumonia. Four further cases had CRP values below 100 mg/L and negative chest X-rays and, hence, in these cases, the likelihood of an ongoing bacterial infection was relatively low. In the remaining 10 patients, four had CRP values above 100 mg/L, two were diagnosed with chest X-ray findings consistent with pneumonia, and four patients presented with both of the latter findings. In those 10 patients, the possibility of an ongoing bacterial infection was relatively high. In the length-of-stay analysis, a significant difference was found between the two symptomatic cohorts and the controls (p < 0.001), but no difference was observed between the S/PCR− and S/PCR+ cohorts (p = 0.39) (Fig. 1). Subgroup analysis of patients admitted by general practitioners to the hospital with a tentative diagnosis of pneumonia or patients with chest X-ray at admittance consistent with pneumonia revealed no significant difference between the two symptomatic groups.
Fig. 1

Cumulative length of stay in the three cohorts. Length-of-stay analysis was performed by Cox regression. The length of stay differed significantly between the three cohorts (p < 0.001), but not when comparing the two symptomatic cohorts S/PCR+ and S/PCR− (p = 0.39)

Cumulative length of stay in the three cohorts. Length-of-stay analysis was performed by Cox regression. The length of stay differed significantly between the three cohorts (p < 0.001), but not when comparing the two symptomatic cohorts S/PCR+ and S/PCR− (p = 0.39) No difference between the three cohorts was found with regard to the total CIRS-G score (p = 0.29) and CCI score (p = 0.15) (Table 2). A significantly higher proportion of category four CIRS-G domain scores were found in the S/PCR− cohort (p = 0.032) compared to the S/PCR+ cohort. When comparing the self-reported symptoms between the two symptomatic cohorts, a significant difference was found only for coughing (p = 0.004), which was reported more often in the S/PCR+ than in the S/PCR− cohort (Table 3). No significant difference between the cohorts was found when comparing the number of days spent in intensive care or deaths during the next 12 months.
Table 3

The patients’ self-reported symptoms at the time of study inclusion

S/PCR+S/PCR− p-Value
Cough, %100 (19/19)a 71.5 (89/125)a 0.004
Fever, anamnestic, %73.7 (14/19)a 60.8 (76/125)a 0.321
Phlegm, %52.9 (9/17)a 50.4 (59/117)a 1.000
Nasal discharge, %52.6 (10/19)a 31.2 (39/125)a 0.075
Sore throat, %42.1 (8/19)a 21.6 (27/125)a 0.081
No. of symptomatic days, mean (SD)5.8 (3.8)5.7 (5.3)0.940

Persistent, self-reported symptoms at the time of study inclusion, lasting less than 3 weeks. A comparison between the two groups was performed by the use of Fisher’s exact two-sided test, with significant p-values at < 0.05

aNumber of patients reporting symptoms/total number of patients

The patients’ self-reported symptoms at the time of study inclusion Persistent, self-reported symptoms at the time of study inclusion, lasting less than 3 weeks. A comparison between the two groups was performed by the use of Fisher’s exact two-sided test, with significant p-values at < 0.05 aNumber of patients reporting symptoms/total number of patients

Discussion

The main conclusions of this study of elderly patients hospitalized with symptoms of respiratory tract infections were: (1) a positive viral diagnosis by PCR resulted in the discontinuation of antibacterial treatment in only a minority of the cases; (2) symptoms of RVI, regardless of the real-time PCR results, predicted a longer hospital stay; (3) as all our non-symptomatic controls were negative for these common virus types by real-time PCR, the detection of influenza virus or RSV in the nasopharynx of an elderly person with symptoms of a respiratory tract infection was likely to be etiologically relevant. In the S/PCR+ cohort, 6/19 patients were prescribed antibiotics prior to hospitalization and16/19 patients were administered antibiotics at the time of hospitalization. Only 2/16 patients had their antimicrobial treatment discontinued following viral PCR diagnostics. These results are comparable to other studies, where antibiotics were discontinued in 9.1–28.6 % of the patients after receiving a positive rapid viral test [6, 17, 24]. The impact of rapid viral screening on antibiotic administration in children is not easily transferable to the elderly. First, a negative result of PCR in elderly adults is less reliable due to the reduced viral shedding in this age group [9]. Second, even with a positive viral PCR result, there is an understandable reluctance to discontinue antibiotic treatment in the elderly, as immunosenescence and comorbidities render these patients at increased risk for a bacterial co-infection [25]. Unfortunately, the elderly may be particularly vulnerable to the consequences of inappropriate use of antibiotics, such as adverse drug events, super-infection by Clostridium difficile, and, ultimately, selection of resistant bacteria [26]. Due to their reduced physiological reserves, residents in long-term care facilities seem to be at particular risk in this regard [27, 28]. It is conceivable that the subgroup of elderly patients needing hospitalization for a respiratory tract infection is more frail than the average elderly population. To our knowledge, no frailty assessments using validated scales in combination with real-time viral PCR have been performed in this patient group. In the present study, no difference in comorbidity measured by the total CIRS-G and CCI scores was found between the three hospitalized groups, but no comparison could be made in this regard with a representative group of non-hospitalized elderly individuals. The present control group was younger and less likely to reside in a nursing home than the symptomatic groups. With the often atypical clinical presentation of an RVI in elderly patients, adherence to clinical guidelines might be difficult, often due to difficulties with the initial diagnosis [9, 23]. In the present study, a tentative pneumonia diagnosis at admission was confirmed by chest X-ray in only half of the patient population. In one study, a local educational program for the treatment of respiratory infections in the elderly significantly reduced the prescription rate and influenced the types of antibiotics prescribed [29], thus indicating the effectiveness of age-adjusted guidelines of antibiotic treatment also in elderly patients. No difference in the length of stay was found between the two symptomatic cohorts. These results are in accordance with previous studies in the elderly, where no difference in length of stay was observed between influenza-positive and influenza-negative patients hospitalized due to respiratory symptoms [6]. Studies performed by Lee et al. have shown a decrease in the average length of stay with antiviral treatment [30]. None of our seven influenza-positive patients received antiviral treatment, which, in an early phase of the disease, might have decreased the average length of stay in the S/PCR+ cohort. Nineteen percent of the patients in our study reported at least one symptom consistent with an acute respiratory infection. As in most viral infections of the respiratory tract the shedding declines rapidly, there is a high risk of obtaining a swabbed sample with a virus concentration below the detection threshold, especially a few days after the start of symptoms [8, 9]. The strengths of this study are the prospective design, the relatively high number of patients included, and the use of real-time PCR for virological analysis. Also, since our hospital is the only general hospital in the county of Aust-Agder, our patients are representative for the elderly hospitalized population in our region. In addition, the low number of specially trained staff harvesting the viral samples minimized the risk of poor-quality samples. A limitation to this study is the low number of patients with positive viral swabs. Economical considerations prohibited PCR analysis for rhinovirus and coronavirus; an inclusion of these viruses in the PCR panel could have improved the number of virus-positive swabs. Although final conclusions regarding antibiotic use and length of stay in this patient group are not possible based on this study alone, we believe that our results contribute to improved knowledge of the impact of real-time PCR for respiratory viruses in the elderly. In conclusion, this study of elderly patients reporting symptoms of an RVI has shown that access to an early viral diagnosis had limited impact on the antimicrobial treatment. The challenge related to unnecessary antibiotic treatment in the elderly needs to be addressed, both in research and in guidelines. Below is the link to the electronic supplementary material. Diagnosis of admittance for the three cohorts. (DOCX 12 kb)
  29 in total

Review 1.  Measuring comorbidity in older cancer patients.

Authors:  M Extermann
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale.

Authors:  M D Miller; C F Paradis; P R Houck; S Mazumdar; J A Stack; A H Rifai; B Mulsant; C F Reynolds
Journal:  Psychiatry Res       Date:  1992-03       Impact factor: 3.222

4.  Impact of rapid diagnosis on management of adults hospitalized with influenza.

Authors:  Ann R Falsey; Yoshihiko Murata; Edward E Walsh
Journal:  Arch Intern Med       Date:  2007-01-22

5.  Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial.

Authors:  W F Carman; A G Elder; L A Wallace; K McAulay; A Walker; G D Murray; D J Stott
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

6.  Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable.

Authors:  Siobhain Mulrennan; Simone Sara Tempone; Ivan Thian Wai Ling; Simon Hedley Williams; Gek-Choo Gan; Ronan John Murray; David John Speers
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

7.  Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections.

Authors:  James B Mahony; Gord Blackhouse; Jesse Babwah; Marek Smieja; Sonya Buracond; Sylvia Chong; William Ciccotelli; Tim O'Shea; Daifallah Alnakhli; May Griffiths-Turner; Ron Goeree
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

8.  Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults.

Authors:  Coley B Duncan; Edward E Walsh; Derick R Peterson; F Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

9.  Factors associated with early hospital discharge of adult influenza patients.

Authors:  Nelson Lee; Paul K S Chan; Kin Wing Choi; Grace Lui; Bonnie Wong; Clive S Cockram; David S C Hui; Raymond Lai; Julian W Tang; Joseph J Y Sung
Journal:  Antivir Ther       Date:  2007

10.  Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults.

Authors:  A R Falsey; R M McCann; W J Hall; M M Criddle
Journal:  J Am Geriatr Soc       Date:  1996-01       Impact factor: 5.562

View more
  13 in total

1.  Noninterruptive Clinical Decision Support Decreases Ordering of Respiratory Viral Panels during Influenza Season.

Authors:  Cameron Escovedo; Douglas Bell; Eric Cheng; Omai Garner; Alyssa Ziman; Sitaram Vangala; Prabhu Gounder; Carlos Lerner
Journal:  Appl Clin Inform       Date:  2020-04-29       Impact factor: 2.342

2.  Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.

Authors:  Daniel A Green; Letiana Hitoaliaj; Brian Kotansky; Sheldon M Campbell; David R Peaper
Journal:  J Clin Microbiol       Date:  2016-09-21       Impact factor: 5.948

3.  Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients.

Authors:  Sunita Mulpuru; Shawn D Aaron; Paul E Ronksley; Nadine Lawrence; Alan J Forster
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

4.  Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Authors:  Makeda Semret; Ian Schiller; Barbara Ann Jardin; Charles Frenette; Vivian G Loo; Jesse Papenburg; Shelly A McNeil; Nandini Dendukuri
Journal:  J Infect Dis       Date:  2017-11-15       Impact factor: 5.226

5.  Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions.

Authors:  Inger van Heijl; Valentijn A Schweitzer; Lufang Zhang; Paul D van der Linden; Cornelis H van Werkhoven; Douwe F Postma
Journal:  Drugs Aging       Date:  2018-05       Impact factor: 3.923

6.  Respiratory tract virus infections in the elderly with pneumonia.

Authors:  Matti Aronen; Laura Viikari; Ia Kohonen; Tytti Vuorinen; Mira Hämeenaho; Maarit Wuorela; Mohammadreza Sadeghi; Maria Söderlund-Venermo; Matti Viitanen; Tuomas Jartti
Journal:  BMC Geriatr       Date:  2019-04-16       Impact factor: 3.921

7.  Opportunities Revealed for Antimicrobial Stewardship and Clinical Practice with Implementation of a Rapid Respiratory Multiplex Assay.

Authors:  Zoe F Weiss; Cheston B Cunha; Alison B Chambers; Audrey V Carr; Cleo Rochat; Mariska Raglow-Defranco; Diane M Parente; Aimee Angus; Leonard A Mermel; Latha Sivaprasad; Kimberle Chapin
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

8.  The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study.

Authors:  Mayanka Tickoo; Robin Ruthazer; Amit Bardia; Shira Doron; Gabriela M Andujar-Vazquez; Bradley J Gardiner; David R Snydman; Sebastian G Kurz
Journal:  BMC Pulm Med       Date:  2019-07-01       Impact factor: 3.317

9.  Contribution of the FilmArray Respiratory Panel in the management of adult and pediatric patients attending the emergency room during 2015-2016 influenza epidemics: An interventional study.

Authors:  L Busson; M Bartiaux; S Brahim; D Konopnicki; N Dauby; M Gérard; P De Backer; K Van Vaerenbergh; B Mahadeb; L Mekkaoui; M De Foor; M Wautier; O Vandenberg; P Mols; J Levy; M Hallin
Journal:  Int J Infect Dis       Date:  2019-03-26       Impact factor: 3.623

Review 10.  Testing for Respiratory Viruses in Adults With Severe Lower Respiratory Infection.

Authors:  James M Walter; Richard G Wunderink
Journal:  Chest       Date:  2018-06-14       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.